Victoza Caused Side Effects in 80% of Children, But Helped Them Lose Weight: Study
Most of the adverse events were gastrointestinal in nature, mirroring claims being raised in thousands of Ozempic lawsuits filed over stomach paralysis and ileus.
Most of the adverse events were gastrointestinal in nature, mirroring claims being raised in thousands of Ozempic lawsuits filed over stomach paralysis and ileus.
Use of Ozempic, Wegovy, Mounjaro and other GLP-1 drugs has spiked in recent years due to their effectiveness promoting weight loss, but side effects often cause users to discontinue the treatment within the first year.
Drug makers hope to defeat failure to warn charges during hearings over certain cross-cutting issues, later in the GLP-1 litigation.
Scientists call for more research into the association between drugs like Ozempic and Mounjaro and thyroid cancer.
Researchers found that GLP-1 drugs benefit those with diabetes or obesity, but more than double the risk of acute pancreatitis and cause other side effects.
The extensive pretrial proceedings mean the first Ozempic bellwether trials are unlikely to begin until at least 2026 or 2027.
With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.
Lawsuit claims Novo Nordisk's failures to warn about the risk of gastroparesis and Ileus from Ozempic were "wanton, willful, fraudulent, reckless acts."
The Court may soon allow future lawsuits over Ozempic, Wegovy, Mounjaro and other GLP-1s to be brought using a Short Form Complaint, adopting allegations from the MDL Master Complaint.
Side effects of Wegovy caused a West Virginia woman to develop severe gastrointestinal problems, ileus and the need for her gallbladder to be surgically removed.